Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →21
🟡 Moderate
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
6,471
Total Claims
$698K
Drug Cost
657
Beneficiaries
$1,062
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,404 Physical Medicine and Rehabilitation providers
+177%
Opioid rate vs peers
55.9% vs 20.2% avg
+133%
Cost per patient vs peers
$1,062 vs $455 avg
+165%
Brand preference vs peers
8.3% vs 3.1% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
55.9%
Opioid Rate
3,619
Opioid Claims
$405K
Opioid Cost
15.6%
Long-Acting Rate
This provider's opioid prescribing rate of 55.9% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 538 claims · $461K
Generic: 5,933 claims · $237K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Buprenorphine Hcl | 266 | $243K |
| Buprenorphine Hcl/Naloxone Hcl | 330 | $49K |
| Hydrocodone/Acetaminophen | 1,598 | $46K |
| Rimegepant Sulfate | 38 | $43K |
| Methylnaltrexone Bromide | 15 | $37K |
| Oxycodone Hcl/Acetaminophen | 868 | $34K |
| Buprenorphine Hcl/Naloxone Hcl | 33 | $29K |
| Buprenorphine | 62 | $21K |
| Pregabalin | 26 | $19K |
| Oxycodone Hcl | 47 | $18K |
| Ubrogepant | 16 | $18K |
| Pregabalin | 455 | $18K |
| Gabapentin | 569 | $12K |
| Buprenorphine | 16 | $12K |
| Tapentadol Hcl | 11 | $12K |
Prescribing Profile
42
Unique Drugs
21.0
Anomaly Score
Patient Profile
69
Avg Age
67%
Female
1.60
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About